Iduronidase-transposed human B lymphocytes correct enzyme deficiency and glycosaminoglycan storage disease in immunodeficient mucopolysaccharidosis type I mice

被引：0
|
作者：
Hampe, Christiane S. [1 ]
Meeker, Kole D. [1 ]
Swietlicka, Monika [1 ]
Olson, Erik R. [2 ]
Lund, Troy C. [3 ]
Wesley, Jacob [1 ]
McIvor, R. S. [2 ]
机构：
[1] Immusoft, Seattle, WA USA
[2] Immusoft, Minneapolis, MN USA
[3] Univ Minnesota, Minneapolis, MN USA
来源：
MOLECULAR GENETICS AND METABOLISM | 2022年 / 135卷 / 02期
关键词：
D O I：
10.1016/j.ymgme.2021.11.129
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
114
引用
收藏
页码：S53 / S53
页数：1
相关论文
共 20 条
  • [11] Intra-articular enzyme replacement therapy with recombinant human iduronidase is safe and well-tolerated in the canine model of mucopolysaccharidosis type I
    Wang, R.
    Aminian, A.
    Kan, H.
    Le, S.
    Guerra, C.
    Dickson, P.
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (03) : 360 - 361
  • [12] Correction of storage disease in MPS I mice by adoptive transfer of human B cells engineered for human iduronidase expression using the Sleeping Beauty transposon system
    McIvor, R. S.
    Olson, E.
    de laat, R.
    Xu, M.
    Swietlicka, M.
    Hyland, K. A.
    Hall, Z.
    Herbig, E.
    Scholz, M.
    HUMAN GENE THERAPY, 2017, 28 (12) : A68 - A69
  • [13] Genome Edited Human Hematopoietic Stem Cells Correct Lysosomal Storage Disorders: Proof-of-Concept and Safety Studies for Mucopolysaccharidosis Type I and Gaucher Disease
    Gomez-Ospina, Natalia
    Scharenberg, Sam Glynne
    Mostrel, Nathalie
    Raj, Nitin
    Attardi, Laura
    Khan, Shaukat
    Tomatsu, Shunji
    Lee, Ciaran
    Bao, Gang
    Porteus, Matthew H.
    MOLECULAR THERAPY, 2019, 27 (04) : 329 - 329
  • [14] Progressive heart disease in mucopolysaccharidosis type I mice may be mediated by increased cathepsin B activity
    Baldo, Guilherme
    Vicente Tavares, Angela Maria
    Gonzalez, Esteban
    Poletto, Edina
    Mayer, Fabiana Quoos
    Matte, Ursula da Silveira
    Giugliani, Roberto
    CARDIOVASCULAR PATHOLOGY, 2017, 27 : 45 - 50
  • [15] Enzyme replacement with a blood-brain barrier-penetrating antibody-fused alfa-L-iduronidase prevents neurobehavioral performance of mucopolysaccharidosis type I mice
    Morimoto, Hideto
    Kida, Sachiho
    Minami, Kohtaro
    MOLECULAR GENETICS AND METABOLISM, 2022, 135 (02) : S85 - S85
  • [16] Limited transgene immune response and long-term expression of human α-L-iduronidase in young adult mice with mucopolysaccharidosis type I by liver-directed gene therapy
    Di Domenico, C.
    Di Napoli, D.
    Gonzalez y Reyero, E.
    Lombardo, A.
    Naldini, L.
    Di Natale, P.
    HUMAN GENE THERAPY, 2006, 17 (11) : 1112 - 1121
  • [17] Intranasal Adeno-Associated Virus Mediated Gene Delivery and Expression of Human Iduronidase in the Central Nervous System: A Noninvasive and Effective Approach for Prevention of Neurologic Disease in Mucopolysaccharidosis Type I
    Belur, Lalitha R.
    Temme, Alexa
    Podetz-Pedersen, Kelly M.
    Riedl, Maureen
    Vulchanova, Lucy
    Robinson, Nicholas
    Hanson, Leah R.
    Kozarsky, Karen F.
    Orchard, Paul J.
    Frey, William H., II
    Low, Walter C.
    McIvor, R. Scott
    HUMAN GENE THERAPY, 2017, 28 (07) : 576 - 587
  • [18] Lymphocytes are not required for the rapid onset of coronary heart disease in scavenger receptor class B type I apolipoprotein E double knockout mice
    Karackattu, SL
    Picard, MH
    Krieger, M
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (04) : 803 - 808
  • [19] Recombinant human acid α-glucosidase enzyme therapy for infantile glycogen storage disease type II:: Results of a phase I/II clinical trial
    Amalfitano, A
    Bengur, AR
    Morse, RP
    Majure, JM
    Case, LE
    Veerling, DL
    Mackey, J
    Kishnani, P
    Smith, W
    McVie-Wylie, A
    Sullivan, JA
    Hoganson, GE
    Phillips, JA
    Schaefer, GB
    Charrow, J
    Ware, RE
    Bossen, EH
    Chen, YT
    GENETICS IN MEDICINE, 2001, 3 (02) : 132 - 138
  • [20] Novel first-dose adverse drug reactions during a phase I trial of olipudase alfa (recombinant human acid sphingomyelinase) in adults with Niemann-Pick disease type B (acid sphingomyelinase deficiency)
    McGovern, Margaret M.
    Wasserstein, Melissa P.
    Kirmse, Brian
    Duvall, W. Lane
    Schiano, Thomas
    Thurberg, Beth L.
    Richards, Susan
    Cox, Gerald F.
    GENETICS IN MEDICINE, 2016, 18 (01) : 34 - 40
12